Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM63A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | KLHL15 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | TLR6 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | SYMPK | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | WDTC1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | SHPRH | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | EPHX3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | LYSMD4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | GAGE2A | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | GSAP | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |